LUTETIUM-177 PSMA Radioligand
177Lu-PNT2002 in ACC (terminated, n 1)
Radboud UMC; Johns Hopkins (investigators) · Phase 2 · Terminated · Enrollment 1
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.
ACC
Programs, trials, and reported response and survival for adenoid cystic carcinoma.
LUTETIUM-177 PSMA Radioligand
Radboud UMC; Johns Hopkins (investigators) · Phase 2 · Terminated · Enrollment 1
| Arm | Population | Dose | Estimand | Comparator | Efficacy |
|---|
No efficacy figure is in this file for this study.